Ryan Tedford, MD
Advanced Heart Failure and Transplant Cardiology · Charleston, SCNPI 1104972751
Payments from drug & device makers
Across 507 payments — averaging $1163.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$247K
- Edwards Lifesciences$139K
- Medtronic$74K
- Abbott$61K
- Abiomed$19K
- Endotronix, Inc.$15K
- plus $35K from 13 others
Across 1 payment — averaging $520.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- United Therapeutics Corporation$520
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 155 | $247,370 |
| Edwards Lifesciences | 102 | $138,661 |
| Medtronic(2 entities) | 45 | $74,107 |
| Abbott | 115 | $61,049 |
| Abiomed | 14 | $19,301 |
| Endotronix, Inc. | 6 | $14,597 |
| United Therapeutics Corporation | 20 | $8,247 |
| Boston Scientific | 9 | $6,504 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $6,000 |
| Acceleron Pharma, Inc. | 1 | $5,340 |
| Cvrx, Inc. | 19 | $2,586 |
| Tempus AI, Inc | 1 | $2,293 |
| Ancora Heart, Inc. | 6 | $2,213 |
| Actelion Pharmaceuticals US, Inc. | 5 | $1,118 |
| Novartis | 2 | $231 |
| Boehringer Ingelheim | 1 | $92 |
| Sandoz | 1 | $76 |
| Briohealth Solutions, Inc. | 1 | $32 |
| Lightforce Orthodontics, Inc. | 1 | $15 |
How this compares
$589,832 in reported general payments places this provider in the 85th percentile of 30 advanced heart failure and transplant cardiology providers in South Carolina.
See all advanced heart failure and transplant cardiology providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other advanced heart failure and transplant cardiology in Charleston
- Daniel SilvermanCharleston$1.2M
- Sheldon LitwinCharleston$1.1M
- Brian HoustonCharleston$525K
- Michael ZileCharleston$393K
- Daniel JudgeCharleston$380K
- Gregory JacksonCharleston$379K
- Adrian VanbakelCharleston$360K
- Ramsey WehbeCharleston$183K
- Jan GriffinCharleston$81K
- Vishal RaoCharleston$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.